PROBLEMATIKA DISLIPEDEMIA DI INDONESIA

Dyslipdemia is a public health problem in Indonesia which prevalance always increasing every year. Dylipidemia characterized by disorder of lipid metabolism in blood circulation which increase of total cholesterol level, LDL, TG, and alleviate of HDL level. Dyslipidemia is the primary cause for the developmen of cardiovascular disease. Dylipidemia generated by genetic disorders or other conditions such as obesity, diabetes mellitus, alcohol consumption and various other conditions. First treatment of dyslipidemia must be from non-pharmacological which diet control, excercise dan should to avoid smoking and alcohol. Pharmacological therapi applied when non-pharmocological therapy failed or the condition which need drugs to control lipid metabolism. Statin group choses as primary pharmacological therapy for dyslipidemia. Therapy for dyslipidemia concentrated to control LDL level in blood circulation. In this regard, the study purpose was to study dyslipidemia from the lipid metabolism disorder until that therapy